Strata Critical Medical, Inc. — Cyborg Score 5/10

Mixed
Healthcare Services - Medical Logistics & Organ Transplant Services

Strategic Profile

Strata operates one of the nation's largest air transport and surgical services networks for transplant hospitals, offering integrated organ recovery solutions including air and ground logistics, surgical organ recovery, organ placement, normothermic regional perfusion, and perfusion staffing services under the Trinity Medical Solutions and Keystone Perfusion brands. Co-CEOs Melissa Tomkiel and Will Heyburn emphasize the company's transformation into an 'end-to-end organ recovery platform' with opportunities to consolidate market share.

Cyborg Score Rationale

Q3 2025 results showed an earnings miss but strong 36.7% year-over-year revenue growth and a robust $76M cash position with no debt. Stock remains significantly below 52-week highs amid post-transformation integration challenges.

Top Insights

  • Management raised 2025 revenue guidance to $185-195M and reaffirmed adjusted EBITDA guidance of $13-14M following the strategic acquisition of Keystone Perfusion.
  • Analyst consensus 12-month price target is $9.625, suggesting 125% upside from current levels.
  • Stock trading 28.9% below 52-week high despite strong growth metrics and strategic repositioning into essential healthcare services
  • Post-rebranding integration and expansion into end-to-end organ recovery platform provides significant consolidation opportunity in fragmented market

Named Competitors

  • Regional organ procurement organizations — Local/regional organ recovery and logistics services
  • Hospital internal logistics — In-house organ recovery and transport capabilities
  • LifeNet Health services — Organ and tissue procurement and recovery services

Recent Developments

  • (Aug 2025) Completed transformation from Blade Air Mobility to Strata Critical Medical; divested passenger aviation division to Joby Aviation
  • (Q3 2025) Revenue increased 36.7% YoY to $49.3M; acquired Keystone Perfusion to strengthen organ recovery platform
  • (Nov 2025) Announced inaugural Investor Day with 2026 guidance and medium-term targets

Open the full interactive Strata Critical Medical, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →